NUGENEREX IMMUNO-ONCOLOGY, INC.

company.status.inactive

CIK 1804585fmd_1739YSZ6KVBGJ8B1BDNPV8AYHYManufacturing · Pharmaceutical PreparationsTemplate: Standard

Coverage: Aug 01, 2018 to Apr 30, 2021, 11 periods

News summary

An AI model writes the summary on request, from this company's recent filings only, and cites each filing it uses.

AI-written

Event typeImportance0 filings

From 8-K filings, not wire news: the items each filer selected on the EDGAR cover, grouped by event type. Importance is FinancialMD's own rule by item number (5: bankruptcy, non-reliance, change of control, delisting, cybersecurity; 1: exhibits only).